Imaging CRISPR-edited CAR-T cell therapies with optical and positron emission tomography reporters.

Theranostics · 2026 · PMC12846014 · PMID 41608579

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Near endpoint, mice receiving CAR-T cells showed a trend towards lower tumor volume compared to the naïve T cell group, without changes in body weight between treatment groups ( Figure 4 D-E ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.